Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Jung, Younghee ^a   Lee, Myung J ^b   Sin, Hye Yun ^a   Kim, Nak Hyun ^b   Hwang, Jeong Hwan ^b   Park, Jinyong ^b   Choe, Pyoeng G ^b,c   Park, Wan B ^b,c   Kim, Eu S ^a,c   Park, Sang Won ^c   Park, Kyoung U ^a,c   Kim, Hong B ^a,c   Kim, Nam Joong ^b,c   Kim, Eui Chong ^b,c   Song, Kyoung Ho ^a,c   Oh, Myoung don ^b,c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Bacteremia; Community acquired infections; Community onset infection; Epidemiology; Healthcare associated; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL FEATURE; COMMUNICABLE DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HEPATOBILIARY SYSTEM INFECTION; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LIVER ABSCESS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NEUTROPENIA; NONHUMAN; PERITONITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; SURVIVAL TIME; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84866854617     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-239     Document Type: Article

References (35)

1. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
2. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med 2006, 34:2588-2595.
3. Valles J, Calbo E, Anoro E, Fontanals D, Xercavins M, Espejo E, Serrate G, Freixas N, Morera MA, Font B, et al. Bloodstream infections in adults: importance of healthcare-associated infections. J Infect 2008, 56:27-34.
4. Kollef MH, Zilberberg MD, Shorr AF, Vo L, Schein J, Micek ST, Kim M. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect 2011, 62:130-135.
5. Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB. The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 2012, 12:85.
6. Liao CH, Chen SY, Chang SC, Hsueh PR, Hung CC, Chen YC. Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital. Diagn Microbiol Infect Dis 2005, 53:85-92.
7. Lesens O, Hansmann Y, Brannigan E, Hopkins S, Meyer P, O'Connel B, Prevost G, Bergin C, Christmann D. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?. Infect Control Hosp Epidemiol 2005, 26:204-209.
8. Pastagia M, Kleinman LC, de la Cruz EG L, Jenkins SG. Predicting risk for death from MRSA bacteremia (1). Emerg Infect Dis 2012, 18:1072-1080.
9. Marschall J, Fraser VJ, Doherty J, Warren DK. Between Community and Hospital: Healthcare-Associated Gram-Negative Bacteremia among Hospitalized Patients. Infect Control Hosp Epidemiol 2009, 30:1050-1056.
10. Cheong HS, Kang CI, Kwon KT, Heo ST, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, et al. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia. J Antimicrol Chemother 2007, 60:1355-1360.
11. Meatherall BL, Gregson D, Ross T, Pitout JD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009, 122:866-873.
12. Wu HS, Wang FD, Tseng CP, Wu TH, Lin YT, Fung CP. Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan. J Infect 2012, 64:162-168.
13. Sun HY, Chen SY, Chang SC, Pan SC, Su CP, Chen YC. Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility. Diagn Microbiol Infect Dis 2006, 55:135-141.
14. Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 2002, 162:1021-1027.
15. Yinnon AM, Butnaru A, Raveh D, Jerassy Z, Rudensky B. Klebsiella bacteraemia: community versus nosocomial infection. QJM 1996, 89:933-941.
16. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004, 140:26-32.
17. Watanakunakorn C, Jura J. Klebsiella bacteremia: a review of 196 episodes during a decade (1980-1989). Scand J Infect Dis 1991, 23:399-405.
18. Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006, 21:816-822.
19. Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wann SR, Lin HH. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 1998, 26:1434-1438.
20. Chung DR, Lee SS, Lee HR, Kim HB, Choi HJ, Eom JS, Kim JS, Choi YH, Lee JS, Chung MH, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 2007, 54:578-583.
21. Fung CP, Chang FY, Lee SC, Hu BS, Kuo BI, Liu CY, Ho M, Siu LK. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?. Gut 2002, 50:420-424.
22. Kim JK, Chung DR, Wie SH, Yoo JH, Park SW. Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 2009, 28:109-111.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
24. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991, 115:585-590.
25. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
26. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. Seventh informational supplement. CLSI document M100-S17 2007, Wayne: CLSI, Clinical and Laboratory Standards Institute (CLSI).
27. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009, 15(Suppl 6):S13-S24.
28. Shin HR. Epidemiology of hepatitis C virus in Korea. Intervirology 2006, 49:18-22.
29. McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 2005, 165:308-313.
30. Son JS, Song JH, Ko KS, Yeom JS, Ki HK, Kim SW, Chang HH, Ryu SY, Kim YS, Jung SI, et al. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. J Korean Med Sci 2010, 25:992-998.
31. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
32. Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003, 9:412-418.
33. Song KH, Jeon JH, Park WB, Park SW, Kim HB, Oh MD, Lee HS, Kim NJ, Choe KW. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producingEscherichia coliandKlebsiellaspecies: a retrospective matched case-control study. BMC Infect Dis 2009, 9:41.
34. Oltean S, TT D., Bondor C, Slavcovici A, Cismaru C, Lupse M, Muntean M, Jianu C, Marcu C, Oltean M. Charlson's weighted index of comorbidities is useful in assessing the risk of death in septic patients. J Crit Care 2012, 27:370-375.
35. Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003, 37:794-799.